ID: ALA4474640

Max Phase: Preclinical

Molecular Formula: C44H51N7O8S

Molecular Weight: 838.00

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(OC[C@@H]3CCC(=O)N3)ncc(C#CCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)c2cc1C(N)=O

Standard InChI:  InChI=1S/C44H51N7O8S/c1-25-38(60-24-48-25)27-13-11-26(12-14-27)20-46-41(56)34-17-30(52)22-51(34)43(57)39(44(2,3)4)50-36(53)10-8-6-7-9-28-21-47-42(59-23-29-15-16-37(54)49-29)32-19-35(58-5)33(40(45)55)18-31(28)32/h11-14,18-19,21,24,29-30,34,39,52H,6,8,10,15-17,20,22-23H2,1-5H3,(H2,45,55)(H,46,56)(H,49,54)(H,50,53)/t29-,30+,34-,39+/m0/s1

Standard InChI Key:  WLGYLLMBDVTXGV-LAZPJEFXSA-N

Associated Targets(Human)

VHL/IRAK4 32 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 838.00Molecular Weight (Monoisotopic): 837.3520AlogP: 3.76#Rotatable Bonds: 14
Polar Surface Area: 215.17Molecular Species: NEUTRALHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.13CX Basic pKa: 2.65CX LogP: 2.08CX LogD: 2.08
Aromatic Rings: 4Heavy Atoms: 60QED Weighted: 0.09Np Likeness Score: -0.35

References

1. Nunes J, McGonagle GA, Eden J, Kiritharan G, Touzet M, Lewell X, Emery J, Eidam H, Harling JD, Anderson NA..  (2019)  Targeting IRAK4 for Degradation with PROTACs.,  10  (7): [PMID:31312412] [10.1021/acsmedchemlett.9b00219]

Source